Mediterranean Diet in Neurodegenerative Diseases: Recent Advances from Gut–Immune–Brain Axis to Multi-Omics Guided Precision Nutrition
Preprint
- 21 May 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) are increasingly understood as systemic disorders driven by chronic neuroinflammation, metabolic dysregulation, and barrier dysfunction, which interact dynamically along the gut–immune–brain axis. The Mediterranean diet rich in plant-based foods, olive oil, and fish, is consistently associated with reduced cognitive decline and neurodegeneration risk. This review synthesizes recent advances to present a comprehensive framework illustrating how the Mediterranean diet functions as a systems-level modulator. Mechanistically, the Mediterranean diet remodels the gut microbiota, enhancing the production of bioactive metabolites like SCFA-producing bacteria (SCFAs). These metabolites serve as key signaling mediators that reinforce intestinal barrier integrity, reduce systemic inflammation, and subsequently modulate central processes. Within the central nervous system, diet-derived cues influence neuroinflammation by reprogramming microglial and astrocytic states, support mitochondrial function and proteostasis, and help maintain blood–brain barrier (BBB) stability. Disease-specific insights for AD and PD highlight the diet's role in modulating hallmark pathologies such as Amyloid Beta (Aβ), tau, and α-synuclein aggregation. Emerging multi-omics technologies—including single-cell/spatial transcriptomics and microbiome profiling—are reshaping the field, offering unprecedented resolution to dissect these pleiotropic effects. Ultimately, while the Mediterranean diet presents a promising neuroprotective strategy, individual responses vary based on genetics, microbiome, and metabolic context. The integration of these technologies is pivotal for transitioning from generalized dietary advice to precision nutrition approaches tailored to individual patient profiles, positioning the Mediterranean diet not merely as a diet but as a programmable intervention for neuro-immune and metabolic network modulation. Key challenges remain, including the need for more randomized controlled trials (RCTs) and standardized frameworks for multi-omics integration.Keywords
All Related Versions
This publication has 66 references indexed in Scilit:
- Effect modifiers of the MIND diet for cognition in older adults: The MIND diet trialAlzheimer's & Dementia, 2025
- Lycopene Supplemented Mediterranean Diet Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice and Changes Intestinal MicrobiomeJournal of Neuroimmune Pharmacology, 2025
- 2025 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2025
- Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysisAging Clinical and Experimental Research, 2024
- The interaction between Mediterranean diet and intestinal microbiome: relevance for preventive strategies against frailty in older individualsAging Clinical and Experimental Research, 2024
- The Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diet for the Aging Brain: A Systematic ReviewAdvances in Nutrition, 2024
- Plant‐Based Dietary Patterns and Parkinson's Disease: A Prospective Analysis of the UK BiobankMovement Disorders, 2023
- Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiotaJournal of Molecular Medicine, 2023
- Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: Insights and therapeutic approaches from peripheryAgeing Research Reviews, 2021
- Mediterranean Diet and Age-Related Cognitive DeclineJAMA Internal Medicine, 2015